Multiple-center, randomized, open and parallel controlled clinical trial of Nucleoside Analogues: effects and safety on patients with HBV Associated Acute on Chronic Liver Failure.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Actual end date 31 Oct 2011 added as reported by Chinese Clinical Trial Register.
- 05 Mar 2012 New trial record